Research and analysis

Composition of the Respiratory Evidence Panel

Updated 30 March 2023

List of participants

Panel Chair

Gina Radford

Senior Medical Advisor in UKHSA’s coronavirus (COVID-19) Public Health Advice, Guidance and Expertise team, and previous Deputy Chief Medical Officer in England.

Panel members

Pat Cattini (2021 only)

Infection Prevention and Control Nurse and Deputy Director of Infection Prevention and Control at Royal Marsden NHS Foundation Trust

Muge Cevik

Clinical Lecturer in Infectious Diseases and Medical Virology at University of St Andrews and co-opted member of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)

Cariad Evans

Consultant virologist at Sheffield Teaching Hospitals NHS Foundation Trust and member of NERVTAG

Catherine Houlihan

Virology consultant at University College London Hospital (UCLH)

Susie Jerwood

2021: consultant microbiologist at Western Sussex Hospitals NHS Foundation Trust

2022: independent microbiologist, nominated from the British Infection Association (BIA)

Marc Lipman

Professor in Respiratory Infection and HIV Medicine at University College London and Consultant in Respiratory Medicine at Royal Free London NHS Foundation Trust

William Newsholme

Infection Control Consultant at Guys and St Thomas’ NHS Foundation Trust

Catherine Noakes

Professor of Environmental Engineering for Buildings at University of Leeds, leads the Scientific Advisory Group for Emergencies (SAGE) Environment and Modelling Group

Peter Paszkiewicz

Chemist at the Institute for Occupational Safety and Health of the German Social Accident Insurance, Deutsche Gesetzliche Unfallversicherung e.V. (DGUV)

Jenny Poller

Consultant Virologist at NHS Lothian

Jon Szalajda

Deputy Director for National Institute for Occupational Safety and Health (NIOSH)’s National Personal Protective Technology

David Vernez

Professor of Hygiene and Head of Department of Occupational and Environmental Health at Unisanté, University of Lausanne

Jennie Wilson

Professor of Healthcare Epidemiology at University of West London

Peter Wilson

Professor of Microbiology at University College London (UCL)

Stephen Winchester

Consultant Virologist at Frimley Park Hospital NHS Foundation Trust

2022 UKHSA observers

Colin Brown

Infectious Disease Physician, interim Director of Clinical and Emerging Infections, UKHSA

Rachel Clark

Head of COVID-19 Rapid Evidence Service, UKHSA

Daphne Duval

Principal Evidence Reviewer, COVID-19 Rapid Evidence Service, UKHSA

Clare Foster

Public Health Specialty Registrar, Healthcare Associated Infections (HCAI), Fungal, Anti-Microbial Resistant (AMR), Acute Medical Unit (AMU) and Sepsis Division, UKHSA

Carole Fry

Strategic lead - Infection Prevention and Control, HCAI, Fungal, AMR, AMU and Sepsis Division, UKHSA

Carlota Grossi

Senior Evidence Reviewer, COVID-19 Rapid Evidence Service, UKHSA

Sean Harrison

Principal Evidence Reviewer, COVID-19 Rapid Evidence Service, UKHSA

Emma McGuire

Clinical Fellow in Infectious Diseases and Microbiology, HCAI, Fungal, AMR, AMU and Sepsis Division, UKHSA

Ashely Sharp

Consultant Epidemiologist, HCAI, Fungal, AMR, AMU and Sepsis Division, UKHSA

2021 UKHSA (previously Public Health England (PHE)) observers

Colin Brown

Infectious Disease Physician, interim Deputy Director of National Infection Service, PHE

Rachel Clark

Head of COVID-19 Rapid Evidence Service, PHE

Daphne Duval

Senior Evidence Reviewer, COVID-19 Rapid Evidence Service, PHE

Carole Fry

Lead for Infection Prevention and Control, PHE

Emer O’Connell

Consultant in Public Health, Advice and Guidance, PHE

Nicola Pearce-Smith

Senior Information Scientist, COVID-19 Rapid Evidence Service, PHE

Lesley Smith

Lead for Infection Control, PHE

Fatima Wurie

Public Health Scientist, Advice and Guidance, PHE

Register of participants’ interests

Panel members were required to declare any interests that may have had a bearing on their position in the Respiratory Evidence Panel:

  • Pat Cattini: none
  • Muge Cevik: none
  • Cariad Evans: none
  • Catherine Houlihan: none
  • Susie Jerwood: none
  • Marc Lipman:
    • British Thoracic Society, Tuberculosis Specialist Advisory Group, Chair
    • Non-Tuberculous Mycobacterial (NTM) Network UK, Chair
    • NTM Patient Care UK, Trustee
    • NTM Network UK and NTM Patient Care UK have received unrestricted educational grants from Insmed to cover administrative support to the groups
  • William Newsholme: none
  • Catherine Noakes:
    • co-chair of SAGE Environment and Modelling group, and member of various SAGE task and finish groups (April 2020 to March 2022)
    • research funding to support various projects related to COVID-19 transmission and more broadly on ventilation and airborne infection. This includes Engineering and Physical Sciences Research Council (EPSRC) Hospital Environment Control, Optimisation and Infection Risk Assessment (HECOIRA) project, EPSRC Transport Risk Assessment for COVID Knowledge (TRACK) project, NIHR CONTACT, Department of Health and Social Care (DHSC) and NHS Scotland funding for UV air cleaning, PROTECT National Core Study
    • member World Health Organization (WHO) Environment and Engineering Control Expert Advisory Panel (ECAP), member Europe WHO High Level Expert Group on COVID-19, member SPF Clean Air steering board, member UK Fluids Network steering board
    • working group for Academy of Medical Sciences winter reports (2020 and 2021), Royal Academy of Engineering report on Infection Resilient Buildings, member IMechE COVID-19 pandemic infection control taskforce
    • member of SDCEP working group on dentistry and COVID-19, co-author SBAR from NHS Scotland short life working group (SLWG) on dental aerosols (2020), co-author HTM03-01 ventilation guidance for healthcare, member of short life working groups on ventilation for NHS Scotland (2021), Scottish government (2021) and Cabinet Office (2021)
    • editorial board member for Indoor Air, Building and Environment, Indoor and Built Environment Journals
  • Peter Paszkiewicz:
    • research in filtering Respiratory Protective Devices (RPD)
    • testing and certification of filtering RPD
    • consultation of companies in selection and use of filtering RPD
  • Jenny Poller: none
  • Gina Radford: none
  • Jon Szalajda: none
  • David Vernez: none
  • Jennie Wilson: none
  • Peter Wilson:
    • Drug Safety Monitoring Board biologics (rheumatoid/SLE) Roche (up to 2021)
    • Advisory Board Pfizer for new antibiotic combination (up to 2021)
  • Stephen Winchester:
    • Consultant Medical Virologist, Frimley Health NHS Foundation Trust
    • vice chair, Clinical Virology Network
    • Academic Activities Representative, Royal College of Pathologists